check_circleStudy Completed
Occupational Health
Bayer Identifier:
17312
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Cardiovascular disease risk factors prevalence among Bayer's employees in São Paulo, Brazil
Trial purpose
Introduction: As employees spent most part of their time at the worksite, it provides a venue to address multiple individual risk factors and promote health. The America Heart Association (AHA) defined cardiovascular health using as metrics smoking status, body mass index, physical activity, diet, total cholesterol, blood pressure and fasting blood glucose.
Objective: Evaluate Bayer employees’ cardiovascular health according to the AHA definition and the acceptance to engage in lifestyle change programs.
Methods: By the time of the annual occupational safety periodic medical examination, employees will receive an email with information about the cardiovascular health screening, exams requisition (fasting blood glucose and total cholesterol) and a copy of the written informed consent. If the employee accepts to participate, after providing a written informed consent, he will be evaluated according to the AHA cardiovascular health metrics. Data will be collected at the occupational safety electronic health record. After medical evaluation, employees will receive a printed feedback with their cardiovascular health score and will be referred to indicated lifestyle change programs (healthy weight, smoking cessation, diabetes control, high blood pressure control, dyslipidemia control).
After 12 months we will evaluate the percentage of employees who accept to participate; prevalence of the cardiovascular risk factors and distribution according to the AHA classification in ideal, intermediate and poor; adherence to lifestyle change programs.
Objective: Evaluate Bayer employees’ cardiovascular health according to the AHA definition and the acceptance to engage in lifestyle change programs.
Methods: By the time of the annual occupational safety periodic medical examination, employees will receive an email with information about the cardiovascular health screening, exams requisition (fasting blood glucose and total cholesterol) and a copy of the written informed consent. If the employee accepts to participate, after providing a written informed consent, he will be evaluated according to the AHA cardiovascular health metrics. Data will be collected at the occupational safety electronic health record. After medical evaluation, employees will receive a printed feedback with their cardiovascular health score and will be referred to indicated lifestyle change programs (healthy weight, smoking cessation, diabetes control, high blood pressure control, dyslipidemia control).
After 12 months we will evaluate the percentage of employees who accept to participate; prevalence of the cardiovascular risk factors and distribution according to the AHA classification in ideal, intermediate and poor; adherence to lifestyle change programs.
Key Participants Requirements
Sex
BothAge
20 - N/ATrial summary
Enrollment Goal
361Trial Dates
August 2013 - October 2016Phase
N/ACould I Receive a placebo
NoProducts
No DrugAccepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Sao Paulo, Brazil |
Primary Outcome
- Cardiovascular health metrics on a three-point scale (poor, intermediate, ideal)Metrics are defined by the American Heart Association (AHA) [Lloyd-Jones and cols, 2010]date_rangeTime Frame:1 dayenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Number of participants who are suggested to participate in a lifestyle change program and show up for at least one sessiondate_rangeTime Frame:Up to 4 weeks after cardiovascular examinationenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
BehavioralTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A